· AIM:Toinvestigatefactorsassociatedwithresponses tointravitrealbevacizumab (IVB)innaiveidiopathic choroidalneovascularization (iCNV)byhighdomain opticalcoherencetomography(OCT).
.These neo-vesselsarederivedfromthechoroidalvasculatureand penetratethroughBruch'smembraneintothesubretinalspace whichisatypicalpresentationoftype2CNV [4] .Leakynature ofthesevesselsinmacularregionleadstodisturbanceinthe fluidoutflow betweenthesensoryretinaandBruch's membranewhichresultinseparationofbasementmembrane andinnercollagenouslayer,referredasretinalpigment epithelialdetachmentandvaryingdegreeofretinalpigment epithelialchanges [5] . Varioustreatments,includingphotodynamictherapy(PDT), anti-vascularendothelialgrowthfactor (anti-VEGF)have beenusedtopromotetheremissionofsubretinalfluid(SRF) iniCNV [6] [7] [8] .Intravitrealbevacizumab(IVB),arecombinant humanized monoclonalanti-VEGFantibody,hasbeen reportedtobeeffectiveiniCNVpatients.Recentlyseveral studieshaveclarifyretinalmicrostructuralchanges,choroidal thicknessandvisualacuityimprovementiniCNVeyesafter applicationofanti-VEGFastreatmenttherapy [6] .Various reportshaveshownthatbevacizumab (Avastin;Genetech, Inc.),achievedsignificantvisualeffectsintreatingiCNV [7] . However,thereappearstobevariationintreatmentresponses toIVBandunknownfactorsthatcouldpredictvariable responsetothistreatment [8] [9] [10] [11] [12] [13] . [14] methodtotheHD-OCT acquiredimages.B-scan (vertical)countsandA-scan (horizontal)countsweredeterminedbyidentifyingthefirst andlastscanscontainingSRF.Thedifferencebetweenthe numbersofthefirstandlastscansconstitutedthenumberof scansinvolvedinthemeasurement.
Thus,differenceinA-scanlineequalsthechangein horizontaldimensionoflesionanddifferenceinB-scanline equalsthechangeinverticaldimensionoflesion [14] (SRF volume=differenceinA-scanline伊differenceinB-scanline伊 maximumSRFheight). Forthepurposeofthisstudy,SRFonOCTwasdefinedas homogeneoushyporeflectivespacebetweenneurosensory retinaandRPE [15] .Wedefinedresolutionofretinalfluidsas absenceofSRFevaluatedonOCTscans.Thediameterof CNVwasdefinedasthemaximumhorizontalmarginthat couldbedistinguishedbyOCT [15] .ThicknessofCNVwas definedasthemaximumCNVthicknessabovetheretinal pigmentepitheliallevelthatcouldbedeterminedby hyper-reflectivity [15] . [16] .Thesepathologicalchangesarecloselyrelatedto VEGFexpression.IVBcanbeanattractivetreatmentoption ofiCNV.SeveralstudieshaveevaluatedtheefficacyofIVB foriCNV,showingbeneficialvisualoutcomeandhighsafety profile [6] [7] [8] [9] [10] .Somepatientsrespondedwelltothisdrugwhile othersrespondedpoorly [17] [18] [19] . Inthepresentstudy,20%ofiCNVpatientswithSRFshowed goodabsorptionwithin1moafterasinglesessionofIVB.At lastfollowup,70%ofpatientsachievedgoodresolution, withmeanfollowupof3.6moandmeannumberof1.28依1.50 IVBs.Zhang [10] havefollowedacohortof40patients for12moandthemeannumberofIVBtreatmentswere2 injectionspereyeduring12mofollow-up,resultinginall lesionsconvertingtothecicatricialstage;Intheirstudy,after singleIVB40%ofpatientshavecompleteresolutionof subretinalfluidand70%hadcompleteresolutionof subretinalfluidafteradditionalinjection.Thereasonforthis differenceisnotclear,butinourstudywehaveincluded patientswiththebaselineBCVA(logMAR0.65 0.53)and hencewehavelowerpercentage(20% 40%)resolution aftersingleIVB. Decreaseinchoroidalneovesselsthicknessfindingisin agreementwithShin [15] andFramme [20] in exudativeagerelatedmaculardegenerationpatientsthat reported significantdecreaseinchoroidalneovessels thicknessafterapplicationofanti-VEGF.Consideringshort half-lifeofbevacizumabthatremainsintheeyefor4-6wk, weanalyzeclinicalresultsat1moaftersingleIVBtreatment [21] . Decreaseinchoroidalneovesselsthickness,SRFheightand SRFvolumewasaninterestingfindingand,tothebestof knowledge,hasnotbeenreportediniCNVstudies. TreatmentschemeforiCNVhasyetnotbeenestablished. iCNVhavegoodprognosisnaturally,asindicatedbyHo [4] .Intheirstudy,95%ofthepatientshavesameor bettervisualacuityascomparedtoinitialvision.Similar reportsexistregardingtheprognosisofiCNVinyoung patients.Thereisnocontrolledtrialaboutthissubjectand mostresearchesincludedonlyoneinjection [8, 10] . 
